Are time commitments related to cancer care toxic? Depends on who you ask.The term “time toxicity” has become cancer jargon ...
MedPage Today on MSN
GLP-1 Drugs May Benefit Cancer Patients With Brain Lesions
Retrospective study finds link between blockbuster drugs and longer survival ...
Prostate cancer is the leading cancer among Kenyan men, with an estimated 3,582 men being diagnosed with the disease at some ...
Exercise may reduce cancer-related cognitive impairment among people starting chemotherapy, according to results of a ...
Dr. Will Parsons, of Texas Children’s, discusses evolving therapies, survivorship clinics and tools like Passport For Care for long-term cancer care. For a child diagnosed with cancer, cure is the ...
KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.
Results from a global phase 3 clinical trial led by investigators at Mass General Brigham show that the medication ...
A narrative review examines how generative AI tools such as large language models and vision-language models could assist precision oncology by interpreting genomic data, matching patients to clinical ...
MRD testing in lymphoma grows fast, but varying assays and limited guidelines leave clinicians guessing; trials and standards clarify care.
The Sher-e-Kashmir Institute of Medical Sciences (SKIMS), Soura, has reconstituted the Cancer Consortium for the State Cancer Institute (SCI) in view of the rising burden of cancer and the need to ...
An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...
Students at Apollo High School are preparing to stand tall for a cause this week as they host their annual DanceBlue marathon.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results